— Know what they know.
Not Investment Advice

CMRX NASDAQ

Chimerix, Inc.
1W: +0.2% 1M: +0.8% 3M: +140.6% 1Y: +844.7% 3Y: +82.1% 5Y: +454.6%
$8.54
Last traded 2025-04-21 — delisted
NASDAQ · Healthcare · Biotechnology · $801.1M mcap · 80M float · 5.30% daily turnover · Short 39% of daily vol

Cash Flow Trends

Operating Cash Flow
-$75M -8.5% ▼
Capital Expenditures
$287K -222.5% ▼
5Y CAGR: +12.7%
Free Cash Flow
-$75M -8.8% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$3M +86.3% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$44M-$173M$172M-$82M-$88M
Depreciation & Amort.$402K$167K$98K$1K$94K
Stock-Based Comp.$6M$12M$15M$17M$9M
Change in Working Capital$2M$2M-$3M$2M$7M
Other Non-Cash Items-$14K$58M-$231M-$7M-$4M
Operating Cash Flow-$36M-$100M-$47M-$69M-$75M
— Investing Activities —
Capital Expenditures-$58K-$207K-$71K-$89K-$287K
Acquisitions (Net)$10K-$2K$234M$0$0
Investment Purchases-$74M-$115M-$241M-$128M-$131M
Investment Sales$139M$71M$77M$199M$197M
Other Investing$65M$2K$70M$8K$5M
Investing Cash Flow$65M-$44M$70M$71M$71M
— Financing Activities —
Net Debt Issuance$0$0-$14M$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$1M$5M-$193K$308K$214K
Financing Cash Flow$1M$112M-$13M$308K$7M
Net Change in Cash$30M-$32M$10M$2M$3M
Cash End of Period$47M$15M$26M$28M$31M
Free Cash Flow-$36M-$100M-$47M-$69M-$75M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms